This paper reports on the characterization of the metal binding abilities of mammalian MT4 and their comparison with those of the well known MT1. Heterologous Escherichia coli expression in cultures supplemented with zinc, cadmium, or copper was achieved for MT4 and for its separate ␣MT4 and ␤MT4 domains as well as for MT1 and its ␣MT1 domain in cadmium-enriched medium. The in vivo conformed metal complexes and the in vitro substituted zinc/cadmium and zinc/copper MT4 aggregates were characterized. Biosynthesis of MT4 and ␤MT4 in Cd(II)-supplemented medium revealed that these peptides failed to form the same homometallic species as MT1, thus appearing less effective for cadmium coordination. Conversely, the entire MT4 and both of its domains showed better Cu(I) binding properties than MT1, affording Cu 10 -MT4, Cu 5 -␣MT4 and Cu 7 -␤MT4, stoichiometries that make the domain dependence toward Cu(I) clear. Overall results allow consideration of MT4 as a novel copper-thionein, made up of two copper-thionein domains, the first of this class reported in mammals, and by extension in vertebrates. Furthermore, the in silico protein sequence analyses corroborated the copper-thionein nature of the MT4 peptides. As a consequence, there is the suggestion of a possible physiological role played by MT4 related with copper requirements in epithelial differentiating tissues, where MT4 is expressed.
Postgenomic molecular biology is facing up to the quest for function as its major challenge and possibly the most important bottleneck for its current progression. For some decades, data on new genes/proteins have slowly been accumulated, as a product of classical molecular genetics approaches. Nowadays, the massive outburst of genome projects is dramatically providing long registers of putative gene products without a concomitant development of biochemical and/or physiological role assignment. In particular, function differentiation within gene families deserves special attention 1) because gene duplication plus function differentiation is commonly accepted as the source/driving force of molecular evolution, from the unicellular eukaryota and first metazoa (1, 2) to the chordate/vertebrate (3) world, and 2) because in this case the widely applied homology-based function prediction is worthless unless paralogous members have achieved large differentiation. Wet in vivo and in vitro approaches thus remain the only alternative, not only in ascertaining the function profile for each protein but also in tracing the evolutionary pattern of function acquisition associated with gene duplication.
Mammalian metallothioneins (MTs) 1 clearly illustrate the state of the art in incomplete knowledge of functional differentiation within gene families, even nearly 50 years after the isolation of the first member, MT1, as the kidney response to Cd intoxication in horses (4) . MT are metal-chelating peptides reported in all animals, most plants, and some prokaryotes but only related among different taxonomical groups through their high cysteine content and low molecular weight (classifications available on the World Wide Web at http://www.unizh.ch/ϳ mtpage/classif.html). In vertebrates, MT constitute a family of homology, with gene multiplicity present in birds and mammals. In the latter, tandem duplications originated four MT isoforms, MT1-MT4 (Fig. 1) , and in humans MT1 was further amplified up to 13-fold, a situation not described in rodents or sheep.
Mammalian MT1 and MT2 ability to form stable aggregates either with physiological or xenobiotic metals, as well as the ubiquitous, metal-induced expression of their genes, led to the proposal of homeostasis, transport, and detoxification of metals as main biological roles, although this is still a matter of intense debate and may have a nonunique answer (6, 7) . Isolation of the third family member, MT3, and its identification as a neuronal growth-inhibitory factor (8) , synthesized in neural tissues and down-regulated in patients of Alzheimer's disease (9) , immediately brought about a high commitment to biomedical research. MT3 exclusive function was attributed to its most dissimilar amino acid sequence (70% identity versus MT1/MT2) ( Fig. 1) . Unexpectedly, in 1994, MT4 was identified in human and mouse DNA (10) as a fourth, transcriptionally active, family member. Although MT4 is more similar to MT1/MT2 than MT3, hints of a differential biological function were readily contributed by its unique tissular and developmental specific expression pattern (10) . Mouse MT4 transcription seemed re-* This work was supported by Spanish Ministerio de Ciencia y Tecnología Projects BIO2000-0910, BIO2003-03892, and BQU2001-1976. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. stricted to the stratified squamous epithelia of the upper digestive tract, tail, footpads, and vagina, all in cornified layers acting as protective surfaces, plus the maternal deciduum and neonatal skin (10, 11) . Furthermore, classic MT1 inducers such as divalent metal ions or bacterial endotoxins (lipopolysaccharide) had a reduced effect on MT4 (11) . Evolutionary studies locate MT4 as the most ancient mammalian form in the maximum parsimony tree calculated with the 55 available vertebrate MT cDNA sequences (available on the World Wide Web at http://www.unizh.ch/ϳmtpage/trees.html), whereas MT1 would have emerged late in evolution. Paradoxically, although older, MT4 peptides are most similar among themselves (93.4% identity for mouse MT4 versus human MT4) rather than in comparison with the different isoforms within the same organism (55.7% identity for mouse MT4 versus mouse MT1), indicating a stronger functional constraint for MT4 than for MT1. Unfortunately, at this point, the lack of isolation and functional characterization of any MT4 protein precluded any further understanding of mammalian MT differentiation and evolution. When considering the huge amount of molecular, structural, and functional information accumulated for MT1/MT2 and MT3, and the large number of cellular and physiological events (normal and/or pathological) to which they have been related, there is a dire lack of information available for MT4.
Since first described (4), MT1 has been the paradigm for MT. Studies with either synthetic peptides or in vitro reconstituted native metal aggregates provided insights into the structure/ function relationship in MT1, which culminated with the report of the three-dimensional structure of Zn 2 Cd 5 -MT1 (13, 14) . Overall data revealed that this 61-residue peptide, which includes 20 cysteines, folds into two domains when coordinating divalent metal ions, the N-terminal segment (␤ domain) giving rise to an M II 3 (S-Cys) 9 complex and the C-terminal segment (␣ domain) giving rise to an M II 4 (S-Cys) 11 aggregate. Subsequent analyses of the in vitro affinity of the MT1 fragments to physiological ions (zinc and copper) showed that monovalent metal ions preferentially bind to the ␤MT1 domain, whereas divalent ions prefer to occupy the ␣MT1 counterpart (15) (16) (17) (18) (19) . Further characterization of the metal aggregates obtained by recombinant synthesis of several MTs provided knowledge on their in vivo metal binding preferences, which allowed us to set up a new comprehensive frame for MT classification and evolution (20) . Thus, on the basis of structure/function relationships, we identified MT1 and ␣MT1 as Zn-thioneins (21-23) and the independent ␤MT1 as a Cu-thionein (24, 25) . Currently known Cu-thioneins belong to arthropoda (Drosophila (26, 27) and crustacea (28) ) and unicellular eukaryota (yeasts (29) and ciliate protozoa (30) ).
This work aims at evaluating the character of Zn-or Cuthionein of MT4 through the spectroscopic and spectrometric characterization of the zinc, cadmium, and copper aggregates rendered by full-length recombinant mouse MT4 and its separate ␤ and ␣ domains as well as of the metal species obtained by Zn/Cd or Zn/Cu in vitro replacement. Comparison of these data with those of the paralogous metal-MT1 clusters (this work) (21-25) will shed light on the functional differentiation of MT4 versus MT1 and on the possible MT4 biological roles. Both insights will significantly contribute to the understanding of the duplication and differentiation evolutionary pattern of metallothioneins.
EXPERIMENTAL PROCEDURES
Cloning of the Mouse MT4 Coding Region and Its Independent ␣ and ␤ Domains in an E. coli Expression System-The murine MT4 coding sequence was amplified by PCR, using as a template the MT4 cDNA inserted in a pSP64 plasmid, kindly provided by Dr. Palmiter of the University of Washington. The following oligonucleotides were used as PCR primers: MT4-BamHI (5Ј-GCCGGATCCATGGACCCTGGGGA-3Ј, upstream) and MT4-SalI (5Ј-GCGCGCGTCGACTCAGGGACAGCA-3Ј, downstream). Through this reaction, a BamHI restriction site was introduced before the ATG initiation codon and a SalI site immediately after the stop codon. A 35-cycle PCR amplification (30 s at 94°C (denaturing), 30 s at 55°C (annealing), and 30 s at 72°C (extension)) was carried out in a total reaction volume of 100 l, comprising 2 l of 25 mM dNTP mixture, 2 l of 20 M primer solution, 1 unit of DeepVent (New England Biolabs) thermoresistent DNA polymerase, and 100 ng of the template DNA. The DNA fragments encoding the independent MT4 domains were obtained by mutagenic PCR on the pSP64 template. To amplify the ␣MT4 fragment, which extends from the 32nd MT4 residue (Lys) to the C terminus ( Fig. 1) , a PCR was performed with the ␣MT4-BamHI primer (5Ј-CCCGGATCCATGAAAAGCTGCTGTCC-3Ј, upstream) and the MT4-SalI primer (downstream). The ␤MT4 fragment extends from the ATG initiation codon to the 31st residue (Arg) (Fig. 1) . The primers used for its PCR synthesis were MT4-BamHI (upstream) and ␤MT4-SalI (5Ј-CCGCGCGTCGACCTAACGACAGGTTTTACACG-3Ј, downstream). The conditions for both PCRs were the same as for the entire MT4 cDNA. The construction of MT1 expression vectors has previously been described (21, 22) .
In all cases, the PCR products were isolated from 2% agarose gels, digested with BamHI-SalI and subsequently cloned into the corresponding sites of the pGEX-4T-1 expression vector (Amersham Biosciences). Previous to protein synthesis assays, all of the DNA constructs were confirmed by automatic DNA sequencing (ABI 370; PerkinElmer Life Sciences), using the Amersham Dye Terminator Cycle Kit. JM105 was the E. coli recipient strain for cloning and sequencing purposes, and thereafter, the expression plasmids were transformed into the E. coli protease-deficient strain BL21 for recombinant overexpression.
Recombinant Synthesis and Purification of the Zn-MT4, Cd-MT4, and Cu-MT4 Aggregates-For the characterization of M(II)-MT4 aggregates, recombinant bacteria were grown according to two kinds of conditions. Small scale cultures (1.5 liters, performed in Erlenmeyer flasks) were used for analytical purposes, whereas large scale volumes (at least 10 liters, grown in a Microferm fermentor (New Brunswich), coupled to a Westfalia CSA-1-06-475 centrifuge and controlled by a TVE-OP 76/0 programmer (Braun Biotech)) were used for preparative purposes. In both cases, the transformed E. coli cells were grown as described in Ref. 20 , supplementing the medium either with ZnCl 2 or CdCl 2 to a final concentration of 300 M. In order to characterize the MT4 copper coordination behavior, and due to the special significance of these data, synthesis of MT4 and its independent domains in coppersupplemented medium were assayed in different culture conditions. In short, induction times assayed were 3 h for ␣MT4 and ␤MT4 and 2 and 3 h for the entire MT4; isopropyl-1-thio-␤-D-galactopyranoside final concentration assayed was 100 mM for ␤MT4 and 100 and 200 mM for ␣MT4 and the entire MT4; culture volumes were 1.5 and 5 liters for ␣MT4 and ␤MT4 and 1, 1.5, and 5 liters for the entire MT4. Only the 5-liter assays were performed in the fermentor, the smaller volumes corresponding to Erlenmeyer flask cultures. Purification of all of the recovered metal-MT complexes was performed as described for MT1 (21, 25) . Aliquots of the MT-containing fast performance liquid chromatography fractions in 50 mM Tris-HCl buffer, pH 7.0, were analyzed in 15% SDS-PAGE Coomassie Blue-stained gels. Samples were pooled, aliquoted, and kept at Ϫ80°C under argon atmosphere until further analysis. Inductively coupled plasma-atomic emission spectroscopy (ICP-AES) was used to determine the amount of protein present in the different preparations and the metal/protein ratios, as described in Ref. 31 , measuring sulfur at 182.04 nm, zinc at 213.85 nm, cadmium at 228.80 nm, and copper at 324.75 nm. Additionally, Ellman's method (32) facilitated determining the percentage of thiol groups over total sulfur in the samples by reaction with 5,5Ј-dithiobis(nitrobenzoic acid), except for those aggregates containing copper, since the presence of this metal in MT prevents the applicability of the procedure (33) .
Spectroscopic Characterization of the Metalated MT4 and MT1 Species-Spectroscopic (UV-visible electronic absorption) and spectropolarimetric (CD) analysis of the metal-MT4 clusters and of the species formed in vitro during the zinc/cadmium and zinc/copper displacement studies at pH 7.0 was carried out and processed as described in Refs. 21, 23, and 24. Electronic absorption measurements were performed on an HP-8453 diode array UV-visible electronic absorption spectrophotometer. A Jasco spectropolarimeter (model J-715) interfaced to a computer (GRAMS 32 Software) was used for CD determinations. All assays were performed under argon atmosphere, and titrations were carried out at least in duplicate to assure reproducibility. The pH for all experiments remained constant throughout, without the addition of buffers, and the temperature was kept at 25°C by means of a Peltier PTC-351S apparatus.
Spectrometric Characterization of the Metalated MT4 and MT1 Species-The molecular mass of the Zn-, Cd-, and Cu-MT species obtained in vivo and in vitro was determined by electrospray ionization mass spectrometry (ESI-MS) on a Fisons Platform II instrument, equipped with MassLynx software and calibrated with horse heart myoglobin (0.1 mg/ml). The assay conditions for the zinc-and cadmium-containing species were as follows: 20 l of protein solution injected at 40 l/min; the use of a high performance liquid chromatography Uptisphere C 4 In all cases, the running buffer was an appropriate mixture of acetonitrile and 5 mM ammonium acetate/ammonia, pH 7.5. The molecular mass of the apo-forms was determined as for the coppercontaining species, except that the carrier was a 1:1 mixture of acetonitrile and trifluoroacetic acid, pH 1.5. Masses for the holo-species were calculated as described in Ref. 34 .
In Silico Analysis of DNA and Protein Sequences-Protein sequences were aligned by ClustalW (version 1.75), using the Blosum62 as a distance matrix, and a gap penalty of 10/100, a gap extension value of 0.05/100, and a 40% delay between divergent sequences (35) . The ClustalW alignments were the input for calculating protein distances and constructing the corresponding bootstrap neighbor-joining trees, through the Fitch-Margoliash tree-building algorithm (36) . In this case, 1000 unrooted trees were examined for each bootstrap trial with a random generator seed of 111/1000. The protein distance and treebuilding applications are included in the Phylip software package (37) . The protein sequence similarity analyses were performed using the clusters of zinc-thionein and copper-thionein MT sequences previously characterized (20, 27) .
RESULTS AND DISCUSSION
Cloning and Expression of the MT4-, ␣MT4-, and ␤MT4-cDNA Constructs-DNA sequencing confirmed that the three amplified PCR products corresponded to the entire MT4, ␣MT4, and ␤MT4 coding regions, without the introduction of any undesired nucleotide substitution. The SDS-PAGE analysis of the M-MT4, M-␣MT4, and M-␤MT4 aggregates (where M represents Zn(II), Cd(II), or Cu(I)) synthesized in the corresponding metal supplemented cultures as well as of the Cd-MT1 and Cd-␣MT1 species recovered from Cd-supplemented medium revealed homogeneous preparations at a concentration range of 0.5-7.0 ϫ 10 Ϫ4 M. The identity and integrity of all Metal Binding Abilities of MT4 -Analysis of the monovalent and divalent metal binding capabilities of MT4 was attained through a two-step strategy. First, the in vivo synthesized M-MT4, M-␣MT4, and M-␤MT4 (where M represents zinc, cadmium, and copper) aggregates and the recombinant Cd-MT1 and Cd-␣MT1 species, not previously studied, were characterized. Second, the reaction pathways of the in vitro zinc/cadmium and zinc/copper replacement processes undergone by the three Zn-MT4 peptides at pH 7 were determined using the rationale previously applied for MT1 (21) (22) (23) (24) . Detailed analysis of the spectroscopic (CD and UV-visible electronic absorption) sets of data recorded during these titrations provided information on the number of metal-MT species generated, their stoichiometry, and their degree of folding. Additionally, the spectrometric (ESI-MS) measurements revealed the molecular distribution (38, 39) of the various complex species present at each point of the titrations, and the absence of cooperativeness during the zinc/metal replacements in the three MT4 peptides. However, although it was possible to determine the zinc/cadmium/MT ratios in the heterometallic species formed in the zinc/cadmium replacements, the proximity between the atomic weights of zinc and copper, together with the ESI-MS experimental error range, prevented determination of the zinc/copper/MT ratios for the zinc/copper reactions. When the addition of Chelex-100 did not alter the optical spectra of the solutions, the exact stoichiometry of the heterometallic Cu,Zn-MT species was determined through chelation experiments (23). Other- wise, it was either inferred from the remaining spectroscopic data or denoted as undetermined (Zn x ,Cu n -MT).
In Vivo Zn(II) Binding Abilities of Mouse MT4 and MT1-The biosynthesis of Zn 7 -MT4, Zn 4 -␣MT4, and Zn 3 -␤MT4 as unique metal aggregates in zinc-supplemented cultures (Table  I) confirmed the same binding capacity for each MT4 fragment either alone or when linked together. This independent behavior could be extended to the folding of each domain in Zn 7 -MT, since comparison of the CD fingerprint of Zn 7 -MT4 with that of the sum of Zn 4 -␣MT4 and Zn 3 -␤MT4 revealed only minor differences (Fig. 2) , even less significant than those reported for MT1 (21) or Homarus americanus metallothionein (20) . Thus far, MT4 Zn(II) binding behavior fully mimics that of MT1, although comparison of the CD spectra revealed lower chiralities for the Zn-MT4 peptides with respect to the paralogous Zn-MT1 forms. This suggests that Zn(II) coordination induces a poorer degree of MT4 folding than for that of MT1 and constitutes an initial result for calling into question the Zn-thionein nature of MT4.
In Vivo Cd(II) Binding Abilities of Mouse MT4 and MT1-The results of the protein syntheses in cadmium-enriched cultures enhanced the above mentioned hypothesis that MT4 was not optimal for divalent metal chelation. Of the three MT4 forms, only the ␣MT4 fragment was synthesized as a unique species, Cd 4 -␣MT4, whereas MT4 and ␤MT4 rendered mixtures of the expected homometallic complexes with several heterometallic Zn,Cd-MT aggregates (Table I) . Furthermore, whereas homometallic Cd 3 -␤MT4 aggregate was the major product recovered, the entire MT4 afforded a mixture of species in which Zn 4 Cd 3 -MT was the major form, and Cd 7 -MT, together with Zn 7 -MT, were the minor products. These results show not only the low MT4 ability for Cd(II) coordination in vivo but also the highly dissimilar behavior of its domains. The paralogous MT1 form exhibited a distinct cadmium binding behavior, since all MT1 peptides were synthesized as unique, homometallic cadmium aggregates (i.e. Cd 7 -MT1, Cd 4 -␣MT1 (Table I) , and Cd 3 -␤MT1) (25) . According to the composition of the recombinant samples reported here, only the CD spectra of the Cd 4 -␣MT4, Cd 7 -MT1, and Cd 4 -␣MT1 solutions can be considered representative of the CD fingerprints of these species (data included in Fig. 4) , all showing the characteristic derivative-shaped band at ϳ250 nm of the Cd-MT aggregates (21, 22) . In contrast, the CD spectra of the recombinant Cd-MT4 and Cd-␤MT4 samples (data included in Fig. 4 ) only provided an average of the optical features of the coexisting species. Interestingly, recombinant Cd-MT4 and Cd-␤MT4 were the samples with the highest oxidation degrees found among all the biosynthesized proteins (Table I) .
In Vitro Cd(II) Binding Abilities of Mouse MT4 and MT1-For the sake of brevity, only the CD spectra of the titrations of Zn 7 -MT4, Zn 4 -␣MT4, and Zn 3 -␤MT4 at pH 7 with CdCl 2 (Fig. 3) and the corresponding ESI-MS results (Table II) are shown, whereas the full set of spectroscopic data and some representative MS spectra are provided as supplementary material (Figs. S1-S6) . Analysis of the overall results led to the proposal of the zinc/cadmium replacement pathways shown in Fig. 3 .
The in vitro data provide further evidence of the Cd binding reluctance of the Zn-MT4 peptides. First, although the three expected fully cadmium-loaded species could indeed be generated by zinc/cadmium replacement, this only occurred after the addition of a number of Cd(II) equivalents higher than those stoichiometrically required (Table II) . The ESI-MS analysis also showed that for 4, 3, and 7 eq of Cd(II) added to Zn 4 -␣MT4, Zn 3 -␤MT4, and Zn 7 -MT4, respectively, there was a coexistence of Cd 4 -␣MT4, Cd 3 -␤MT4, and Cd 7 -MT4 with cadmium-underloaded Zn,Cd-MT4 species. As a consequence, the CD fingerprints of the canonical Cd-MT4 forms are only available upon saturation of the spectral signals (i.e. after the addition of 5, 6, and 11 eq of Cd(II) to the respective zinc aggregates). Second, only the Zn 4 -␣MT4 titration ended with a unique species, Cd 4 -
TABLE II Distribution of the metal aggregates present in solution, according to ESI-MS data, during the titration of Zn 4 -␣MT4 (top left), Zn 3 -␤MT4 (top right), and Zn 7 -MT4 (bottom) with CdCl 2 at pH 7 as a function of the number of Cd(II) equivalents added
, the major species; x, species of intermediate abundance; }, the minor species present in solution.
␣MT4, whereas in the other cases, the Cd 3 -␤MT4 and Cd 7 -MT4 aggregates coexisted with cadmium-underloaded zinc-containing species, Zn 1 Cd 2 -␤MT4 and Zn 1 Cd 6 -MT4, even for an important excess of Cd(II) (Table II, top right and bottom). In light of these results, it makes sense to locate the Zn(II) ion remaining in Zn 1 Cd 6 -MT4 within the ␤MT4 domain. Although reluctance in exchanging the last Zn(II) ion in the M3 position of the ␤MT1 aggregate has already been described (40, 41) , the need for an excess of Cd(II) to generate the canonical Cd-MT1 species was never observed (21, 22) .
Comparable Cd(II) binding abilities for ␣MT4 and ␣MT1 can be proposed on the basis of similar zinc/cadmium replacement pathways (Fig. S1 ) and on the match between the CD spectra of the in vitro and in vivo generated Cd 4 -␣MT species (Fig. 4A) , which shows the isostructurality of the four metal aggregates. Isoforms uniquely differ in the higher number of Cd(II) ions required to generate Cd 4 -␣MT4 than to generate Cd 4 -␣MT1. This scenario cannot be extended to ␤MT4. On the one hand, the CD spectrum of the in vivo Cd-␤MT4 sample (Fig. 4B) was reproduced by the addition of 3 eq of Cd(II) to Zn 3 -␤MT4 (Fig.  3B) , confirming a comparable mixture of species in both situations (Table I and Table II , top right). On the other, the CD fingerprint of Cd 3 -␤MT4 did not resemble those of the isostructural Zn 3 -␤MT4, Zn 3 -␤MT1 and Cd 3 -␤MT1 (Figs. 4B and S2 ), indicating that Cd 3 -␤MT4 represents a novel complex. Moreover, this species, unlike Cd 3 -␤MT1 that renders Cd 4 and Cd 9 aggregates (22), does not give rise to any overmetalated species. Finally, when analyzing the entire MT4 folding, the resemblance between the CD spectra of Cd 7 -MT4, Cd 7 -MT1 (Fig.  4C) , Zn 7 -MT4, and Zn 7 -MT1 and the closeness of the Cd(II) titrations of Zn 7 -MT4 and Zn 7 -MT1 (Fig. S3, Table II ) (38) , led us to propose that both Cd 7 -MT species present similar three- 
FIG. 5. Circular dichroism spectra of Cd 4 -␣MT4, Cd 3 -␤MT4, Cd 7 -MT4 and that corresponding to the addition of 8 eq of Cd(II) to Zn 7 -MT4 (A) and of Cd 4 -␣MT4 and those corresponding to the addition of 3 and 8 eq of Cd(II) to Zn 3 -␤MT4 and Zn 7 -MT4, respectively (B).
In both panels, the spectrum depicted in black represents the sum of the circular dichroism spectra of the Cd 4 -␣MT4 and Cd-␤MT4 corresponding species. dimensional structures and are formed through isostructural zinc/cadmium replacement reactions that only differ in their saturation points.
Unlike MT1 (21) (this work), the MT4 fragments do not interact with Cd(II) in the same way when alone or linked together, neither in vivo nor in vitro. Whereas Cd 3 -␤MT4 and Cd 4 -␣MT4 were the major species synthesized, Cd 7 -MT4 was almost absent when the MT4 was expressed in Cd-rich medium. The dependent behavior of both MT4 fragments is also patent in vitro, since the sum of the CD fingerprints of Cd 3 -␤MT4 and Cd 4 -␣MT4 did not compare well with that of Cd 7 -MT4 (Fig. 5A) . However, CD data (Fig. 5B) revealed an independent behavior of both MT4 fragments up to Zn 7 -MT4 plus 8 eq of Cd(II), since at this point the CD spectrum nicely matches the sum of the CD spectra of Cd 4 -␣MT4 and of Zn 3 -␤MT4 ϩ 3 eq of Cd(II) (equivalent to the in vivo Cd-␤MT4). Thus, dependence between domains appeared after the 8th eq of Cd(II) added to Zn 7 -MT4, when the ␣ domain had already achieved a Cd 4 -␣MT4 composition, and the ␤ domain was expected to evolve to Cd 3 -␤MT4 by replacing the last Zn(II) bound. This suggests that linkage of the ␤ domain to its ␣ counterpart hinders the polypeptide rearrangement needed to achieve the novel Cd 3 -␤MT4 folding. This ␤MT4 restriction on structurally behaving as it would if alone could account for the poor capacity of the full-length MT4 to form in vivo-stable Cd 7 -MT4 aggregates.
In Vivo Cu(I) Binding Abilities of Mouse MT4 and MT1-Multiple recombinant syntheses of the entire MT4 in coppersupplemented medium yielded two kinds of results, Type 1 and Type 2, with no evident relationship to any of the assayed culture parameters. Type 1 was a mixture of homometallic copper aggregates, Cu 10 -MT4 being the major species, whereas Type 2 was a mixture of heterometallic M 10 -MT4 (major) and M 8 -MT4 (minor) aggregates (where M represents zinc and copper), with Zn 3 Cu 7 -MT4 as the most abundant species (Table  III) . The CD spectrum of the Type 1 sample could be readily reproduced by the in vitro addition of 2 eq of Cu(I) to Type 2 ( Fig. S7A) , providing evidence for the close relationship between both Cu-MT4 preparations. Thus, an M 10 /MT4 ratio appears the most favored stoichiometry in copper-rich biological medium, M 10 being either Cu 10 or Zn 3 Cu 7 , in an equilibrium depending on biological parameters that, unfortunately, could not be determined. It is worth recalling that MT1 biosynthesis in Cu-rich medium yielded only the Zn 3 Cu 7 -MT1 species (23) .
Contrary to the full-length MT4, several syntheses of recombinant Cu-␣MT4 and Cu-␤MT4 invariantly yielded mixtures of homometallic copper aggregates, Cu 5 -␣MT4 and Cu 7 -␤MT4 being the major respective forms (Table III) , with minor species corresponding to aggregates of lower and exceptionally higher (Cu 7 -␣MT4) stoichiometry. Unfortunately, the CD fingerprints of the biosynthesized Cu 5 -␣MT4 and Cu 7 -␤MT4 species are not available due to the significant abundance of the other coexisting species. ␤MT4 and ␤MT1 show comparable in vivo copper binding behaviors, since they are both produced as mixtures of homometallic, isostoichiometric Cu-␤MT species: Cu 7 -and Cu 6 -␤MT (Table III) (25) . Conversely, the biosynthesis of homometallic Cu-␣MT4 aggregates constitutes an important difference with its ␣MT1 counterpart (23), suggesting that differences in Cu(I) coordination between MT4 and MT1 can be attributed to their ␣-domains.
In Vitro Cu(I) Binding Abilities of Mouse MT4 and MT1-The CD spectra of the Zn 4 -␣MT4, Zn 3 -␤MT4, and Zn 7 -MT4 titrations with [Cu(CH 3 CN) 4 ]ClO 4 at pH 7 are shown in Fig. 6 , whereas the full set of optical and spectrometric data is given as supplementary material (Figs. S8 -S10 and Table S1 ). Overall results allowed the proposal of the zinc/copper replacement reaction pathways of the three Zn-MT species, also shown in Fig. 6 .
Despite slight initial structural dissimilarities, Zn 4 -␣MT4 and Zn 4 -␣MT1 endeavored parallel zinc/copper replacement reactions while there were Zn(II) ions bound. Their behavior diverged after the addition of the 5th or 6th eq of Cu(I), which caused the formation of metal aggregates of different stoichiometry and probably of distinct three-dimensional structure. Finally, the saturation of both peptides rendered species of comparable three-dimensional arrangement (Fig. S8 ), although of different copper contents (Cu 8 -␣MT4 and Cu 9 -␣MT1). ␤MT4 and ␤MT1 exhibit a similar in vitro copperbinding behavior, since both in vitro zinc/copper replacements proceeded analogously (Fig. S9) , but with ␤MT4 showing a higher Cu(I) affinity than ␤MT1; only 4 eq of Cu(I) added to Zn 3 -␤MT4 were needed to form a Cu 6 -␤MT4 species, practically unique in solution (Table S1) , and the addition of up to 6 Cu(I) eq gave rise to a very characteristic CD spectra that could be assigned to the fingerprint of the Cu 7 -␤MT4 aggregate (Fig.  6B) . Species of the same Cu(I)/MT ratio and close three-dimensional structure (Fig. 7) are formed by Cu(I) addition to Zn 3 -␤MT1, but only after 6 and 7 eq of Cu(I), respectively (24) . Furthermore, the unraveling associated with the transition of Cu 7 -␤MT to species of higher stoichiometry is faster for ␤MT4 than for ␤MT1 (i.e. it requires fewer Cu(I) ions, as suggested by the evolution of the respective CD spectra) (Fig. S9) .
Although a first glance at the optical data of the Cu(I) titrations of Zn 7 -MT4 and Zn 7 -MT1 (Fig. S10 ) suggests marked differences, both isoforms evolved similarly until 7 eq of Cu(I) were added, rendering equivalent Zn 3 Cu 7 -MT aggregates, also analogous to the biosynthesized complexes (Fig. S7C) . The apparent dissimilarities in this first stage of the titrations are attributable to the different CD spectra of the starting species; to a small contribution at ϳ350(ϩ) nm characteristic of the ␤MT4 domain (Fig. 6B) and to the lack of cooperative processes in Cu(I) binding to Zn 4 -MT4. As described for the ␣ domain, the main isoform differences appeared concomitantly with the displacement of the last zinc ions bound, now between 6 and 10 eq of Cu(I) added. Then Zn 3 Cu 7 -MT4 gave rise to Cu 10 -MT4, both species clearly different in three-dimensional structure, whereas Zn 3 Cu 7 -MT1 evolved to Zn 1 Cu 10 -MT1, both species sharing a similar three-dimensional structure. According to the CD data, the structures of the in vivo and in vitro Cu 10 -MT4 forms are very close and clearly different from that of Cu 10 Zn 1 -MT1 (Fig. S7B) . Only after displacing the last Zn(II) bound to MT1 do both proteins once more show comparable behavior. Nevertheless, the characteristic ϳ350(ϩ) nm absorption, which intensifies with the formation of Cu 10 -MT4, remained absent in MT1, thus revealing that Cu(I) is bound by MT4 through a coordination environment that MT1 cannot offer and which provides enough stability to the Cu 10 -MT4 aggregates to last in physiological medium. It is also worth noting that for ␣MT4 and the entire MT4, the differences with MT1 are only found in those zinc/copper displacement reaction stages that yield in vitro formation of biologically relevant species, which can be identified by consideration of the in vivo results.
␣MT4 and ␤MT4 do not exhibit an in vivo independent copper binding behavior. As described for MT1 (23) , the in vivo Cu(I) binding capacity is higher for the MT4 separate fragments (Cu 5 -␣MT4 and Cu 7 -␤MT4 as major species) than for the entire protein, since neither Type 1 nor, obviously, Type 2 biosyntheses rendered Cu 12 -MT4 aggregates, as would correspond to the sum of domains, but instead yielded Cu 10 -MT4. Unfortunately, the elucidation of the in vitro dependent/independent behavior of ␣MT4 and ␤MT4 and the proposal of a detailed metal distribution between domains, comparable with that reported for MT1 (23) , are prevented, since the coexistence of species in almost all of the titration points hampers the identification of the CD fingerprints for each species proposed in the reaction pathways of Fig. 6 .
MT4 Structure/Function Relationship-The thorough analysis of the in vivo and in vitro metal binding features of MT4 and MT1 revealed significant differences between isoforms, which can be summarized as improved copper binding and hindered cadmium binding abilities for the MT4 isoform. This, together with the following observations, led us to propose MT4 as a Cu-thionein composed of two Cu-thionein domains, whereas MT1 was previously classified as a Zn-thionein formed by a Cu-thionein (␤MT1) and a Zn-thionein (␣MT1) domain (20) . First, recombinant syntheses in copper-enriched medium afforded homometallic Cu-MT4 species, in contrast to heterometallic Zn 3 Cu 7 -MT1 and Zn 1 Cu 4 -␣MT1 (23) . Second, the three zinc-MT4 complexes showed a patent low chirality. Third, the biosynthesis in cadmium-enriched medium revealed MT4 inability for Cd(II) binding, given that a mixture of cadmium-zinc aggregates was the major product instead of the expected Cd 7 -MT4. Further consideration of the in vitro results corroborated the Cu-thionein character of MT4 and allowed us to ascertain fuller details of its metal binding features. In summary, it was concluded that the better MT4 versus MT1 copper binding ability relies on a different behavior of their ␣MT domains, whereas ␤MT4 exhibits a behavior parallel to, but faster than, ␤MT1. In contrast to this, MT4 cadmium binding reluctance can be attributed to the extreme difficulty of ␤MT4 in forming cadmium-fully loaded aggregates, whereas ␣MT4 shows a cadmium binding behavior analogous to, but slower than, ␣MT1. Thus, to summarize, the differences in Cd(II) coordination between MT4 and MT1 should be assigned to their ␤ domains, the ␣ domains only contributing to these, whereas the opposite situation is found for Cu(I) coordination, the ␣ domains being responsible for the differences, with the ␤ domain harboring an enhancing effect.
Protein sequence distance trees proved powerful enough to discriminate the different metal preferences experimentally determined for MT4 and MT1, thus validating the methodology previously applied for Arthropoda MTs (20, 27) . The full-length MT4 and MT1 and their corresponding fragments were considered separately to avoid distortions caused by the artifactual alignment between an entire polypeptide and one of its halves. MT4 and MT1 shared the closest sequence similarity, as otherwise expected for the comparison between Arthropoda and mammalian sequences, with a branch emerging closer to Cuthioneins than to Zn-thioneins (Fig. 8A) . The results of the study repeated individually for each isoform agreed with their experimental characterization; whereas the MT1 position almost coincided with that of the MT4/MT1 couple, MT4 alone branched from an internal point to the Cu-thionein family (Fig.  8B) . When the MT domains were analyzed, the results remained in close agreement with the wet science data. The tree including the four domains (Fig. 8C) showed association of both ␤MT, clearly inside the Cu-thionein cluster, with both ␣MT in an intermediate position between Zn-and Cu-thioneins, as was the case for the entire MTs. However, both ␤ peptides were situated far apart when individually analyzed (Fig. 8D) , since ␤MT4, but not ␤MT1, moved inside the Cu-thionein group.
Sequence similarity between MT4 and MT1 is almost entirely due to their fully conserved cysteines, since intercalating residues are highly dissimilar. Therefore, these should be made responsible for the differential MT4 and MT1 metal binding behavior. Furthermore, the residue replacement ratios differ substantially between domains. The ␤ domains have considerably diverged during evolution, with up to 62% of their non-Cys residues nonconserved, which is almost twice the ratio in the ␣ domain (35%). ␤MT4 has a Ϫ2 charge with respect to ␤MT1 and contains considerably bulkier amino acids, as shown by a volume increment of ϩ252 (␤MT4 versus ␤MT1) as opposed to ϩ21.2 (␣MT4 versus ␣MT1), calculated according to Ref. 42 . This could entail a severe steric hindrance for the allocation of Cd(II), imposing the particular fold described here for Cd 3 -␤MT4 with respect to Cd 3 -␤MT1 and even to Zn 3 -␤MT4. The diminished Cd(II) binding ability of ␣MT4 versus ␣MT1 could be attributed to its high Pro content, interestingly in Cys-Pro doublets, in agreement with the association of these motifs to structural perturbations interfering with the geometrical requirements of Cd-S clusters recently suggested for MT3 (43) . Non-Cys residues seem to be less determinant for copper interaction, and the ␤MT4 enhanced Cu(I) binding ability may be related to its more negative charge and also to the previously mentioned Pro content, assuming that the turns imposed by the prolyl bonds would yield a polypeptide chain architecture, somehow favoring Cu(I) coordination.
Considerations on MT4 Biological Function-Hypotheses about the MT4 biological function should combine its Cu-thionein character (reported here) and its developmentally controlled, tissue-specific expression pattern (10) . Recent DNA microarray analyses of genes involved in mouse-epidermis differentiation identified MT4 as a target of the transcriptional activator Whn, detecting its expression not only in the squamous epidermis but in all epithelial developing tissues, including hair follicles and the back skin (44) . Therefore, functional genomics not only corroborates but also extends the physiological role of MT4 in mammalian epithelia differentiation. Since the MT1/MT4 transcriptional switch has been reported as coincident with that of k4/k13 keratin subtypes associated to the generation of the outermost epidermic structures (10) , it is tempting to suggest that MT4 would better suit the keratinocyte specific requirements in this specific stage than would MT1. Although an MT4 physiological role involving zinc transport or exchange had been postulated (44) , consideration of the copper requirement of several enzymes involved in the S-S bond formation during keratin biosynthesis would be consistent with MT4 being more optimal in this context due to its Cu-thionein character. Metal analyses of copper smelter workers have also shown that hair and nails are the sites of maximum copper accumulation (12) . This distinctive copper metabolism and avidity in epithelial structures would require the presence of a specific MT form, MT4, whereas essential copper homeostasis and detoxification roles in the organisms would still be carried out by MT1 and MT2 (5) .
In an enlightening review (6), it was stated that "the evolutionary forces that led to the initial appearance, gene duplications, and nearly ubiquitous expression of MTs remain enigmatic." In this work, we are confident of providing evidence that supports a significant functional divergence between the MT4 and MT1 paralogs. This may contribute to the unveiling of further structure/function molecular bases underlying the duplication events that generated the MT family in mammalian genomes.
